Literature DB >> 34995034

Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry.

David S Thylur1, David R Goldsmith.   

Abstract

ABSTRACT: Inflammatory phenomena are found in many psychiatric disorders-notably, depression, schizophrenia, and posttraumatic stress disorder. Inflammation has been linked to severity and treatment resistance, and may both contribute to, and result from, the pathophysiology of some psychiatric illnesses. Emerging research suggests that inflammation may contribute to symptom domains of reward, motor processing, and threat reactivity across different psychiatric diagnoses. Reward-processing deficits contribute to motivational impairments in depression and schizophrenia, and motor-processing deficits contribute to psychomotor slowing in both depression and schizophrenia. A number of experimental models and clinical trials suggest that inflammation produces deficits in reward and motor processing through common pathways connecting the cortex and the striatum, which includes the nucleus accumbens, caudate nucleus, and putamen.The observed effects of inflammation on psychiatric disorders may cut across traditional conceptualizations of psychiatric diagnoses. Further study may lead to targeted immunomodulating treatments that address difficult-to-treat symptoms in a number of psychiatric disorders. In this review, we use a Research Domain Criteria framework to discuss proposed mechanisms for inflammation and its effects on the domains of reward processing, psychomotor slowing, and threat reactivity. We also discuss data that support contributing roles of metabolic dysregulation and sex differences on the behavioral outcomes of inflammation. Finally, we discuss ways that future studies can help disentangle this complex topic to yield fruitful results that will help advance the field of psychoneuroimmunology.
Copyright © 2022 President and Fellows of Harvard College.

Entities:  

Mesh:

Year:  2022        PMID: 34995034      PMCID: PMC8849593          DOI: 10.1097/HRP.0000000000000326

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  182 in total

1.  Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi
Journal:  Psychoneuroendocrinology       Date:  2017-01-24       Impact factor: 4.905

2.  Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.

Authors:  Divya Mehta; Charles L Raison; Bobbi J Woolwine; Ebrahim Haroon; Elisabeth B Binder; Andrew H Miller; Jennifer C Felger
Journal:  Brain Behav Immun       Date:  2013-04-25       Impact factor: 7.217

3.  Beyond depression: the expanding role of inflammation in psychiatric disorders.

Authors:  Andrew H Miller
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

4.  TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.

Authors:  David R Goldsmith; Ebrahim Haroon; Andrew H Miller; Gregory P Strauss; Peter F Buckley; Brian J Miller
Journal:  Schizophr Res       Date:  2018-02-28       Impact factor: 4.939

Review 5.  A systematic, quantitative review of blood autoantibodies in schizophrenia.

Authors:  Amaka Ezeoke; Andrew Mellor; Peter Buckley; Brian Miller
Journal:  Schizophr Res       Date:  2013-08-14       Impact factor: 4.939

6.  Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development.

Authors:  K Juston Osborne; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biomark Neuropsychiatry       Date:  2020-05-12

7.  Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study.

Authors:  Aoife O'Donovan; Ashkan J Ahmadian; Thomas C Neylan; Mark A Pacult; Donald Edmondson; Beth E Cohen
Journal:  Brain Behav Immun       Date:  2016-10-17       Impact factor: 7.217

Review 8.  C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis.

Authors:  Brisa S Fernandes; Johann Steiner; Marc L Molendijk; Seetal Dodd; Patricia Nardin; Carlos-Alberto Gonçalves; Felice Jacka; Cristiano A Köhler; Chandan Karmakar; André F Carvalho; Michael Berk
Journal:  Lancet Psychiatry       Date:  2016-11-10       Impact factor: 27.083

9.  Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident.

Authors:  Panagiota Pervanidou; Gerasimos Kolaitis; Stella Charitaki; Alexandra Margeli; Spyros Ferentinos; Chrysa Bakoula; Christina Lazaropoulou; Ioannis Papassotiriou; John Tsiantis; George P Chrousos
Journal:  Psychoneuroendocrinology       Date:  2007-09-07       Impact factor: 4.905

Review 10.  Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications.

Authors:  Michael J Lucido; Mandy Bekhbat; David R Goldsmith; Michael T Treadway; Ebrahim Haroon; Jennifer C Felger; Andrew H Miller
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 25.468

View more
  1 in total

Review 1.  More than Addiction-The Nucleus Accumbens Contribution to Development of Mental Disorders and Neurodegenerative Diseases.

Authors:  Martyna Bayassi-Jakowicka; Grazyna Lietzau; Ewelina Czuba; Cesare Patrone; Przemysław Kowiański
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.